Page last updated: 2024-10-21

4-aminopyridine and Diabetes Mellitus, Type 1

4-aminopyridine has been researched along with Diabetes Mellitus, Type 1 in 2 studies

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisseling, TM1
Versteegen, MG1
van der Wal, S1
Copius Peereboom-Stegeman, JJ1
Borggreven, JM1
Steegers, EA1
van der Laak, JA1
Russel, FG1
Smits, P1
Troncoso Brindeiro, CM1
Fallet, RW1
Lane, PH1
Carmines, PK1

Other Studies

2 other studies available for 4-aminopyridine and Diabetes Mellitus, Type 1

ArticleYear
Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus.
    American journal of obstetrics and gynecology, 2005, Volume: 192, Issue:3

    Topics: 4-Aminopyridine; Charybdotoxin; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Glyburide; Hum

2005
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.
    American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:1

    Topics: 4-Aminopyridine; Animals; Apamin; Arterioles; Bee Venoms; Diabetes Mellitus, Experimental; Diabetes

2008